Author | Souza, Plinio dos Santos | |
Author | Valadares, Josiel Lopes | |
Access date | 2024-05-01T16:22:55Z | |
Available date | 2024-05-01T16:22:55Z | |
Document date | 2024 | |
Citation | SOUZA, Plínio dos Santos; VALADARES, Josiel Lopes. Collaborative Governance and Turbulence: the experience of the first 100% Brazilian vaccine against COVID-19. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 8., 2024. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2024. p. 118. | en_US |
URI | https://www.arca.fiocruz.br/handle/icict/63801 | |
Language | eng | en_US |
Publisher | Instituto de Tecnologia em Imunobiológicos | en_US |
Rights | open access | en_US |
Subject in Portuguese | Saúde pública | en_US |
Subject in Portuguese | Colaboração | en_US |
Subject in Portuguese | Contextos turbulentos | en_US |
Title | Collaborative Governance and Turbulence: the experience of the first 100% Brazilian vaccine against COVID-19 | en_US |
Type | Papers presented at events | en_US |
DOI | 10.35259/isi.biomang.2024_63801 | |
Abstract | Introduction: We live in turbulent times. Turbulence as a condition and not as a dysfunction (Ansell, Trondal, 2018) instigates research into institutional strategies for overcoming complex public problems such as those experienced in the COVID-19 pandemic. Public health emergencies are examples of these events that require collaboration and interdependence between multiple actors considering the high degree of uncertainty and urgency in their equation. Furthermore, pandemics are at the top of the public problem agenda (Voets, 2021). The research seeks to answer the following question: how to improve Collaborative Governance in public health emergencies in turbulent contexts? Objectives: This research seeks to contribute to the improvement of Collaborative Governance in health emergencies. Since this strategy has been increasingly used to solve complex public problems such as that experienced during the COVID-19 pandemic. Methodology: To contribute to possible answers, the work adopts the case of the first 100% Brazilian vaccine. A robust technological and technology transfer experience between the pharmaceutical company AstraZeneca and Bio-Manguinhos/Fiocruz - a reference public health institution linked to the Brazilian Ministry of Health. This initiative broke organizational boundaries, articulating different actors and civil society, generating more than 203 million doses for the Unified Health System (SUS), mitigating the risks of worsening diseases, hospitalizations and deaths. Results: Preliminary results based on evidence triangulation highlight that a turbulent environment in terms of political style (Lahat, She-Hadar, 2019) proved to be an inhibiting element for a more integrated articulation of collaboration between partners. However, the role of facilitative leadership; the search for a greater common public objective, the sharing of resources and knowledge as well as the prior expertise of partners (Ansell, Gash, 2008) were crucial elements for the success of the Brazilian experience in public health. Concluion: Demonstrates that organizations are configured as structures and/or critical acting agents to influence production, management and adaptation to turbulence (Ansell and Trondal, 2018). In this sense, the importance of organizations preparing for health emergencies is reinforced, as well as the essentiality of recognizing the vaccine as a public good regardless of whether or not it is in an epidemic situation (Trindade, 2022). | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Biomanguinhos). Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Universidade Federal de Viçosa. Viçosa, MG, Brasil. | en_US |
Subject | Public health | en_US |
Subject | Collaboration | en_US |
Subject | Turbulent Contexts | en_US |
xmlui.metadata.dc.subject.ods | 03 Saúde e Bem-Estar | |